Gregg Lemkau on How Investment Banking has Changed in his 28 Years at Goldman Sachs
Gregg Lemkau, co-head of the Investment Banking Division, reflects on how the industry and the firm have changed – and stayed the same – since he joined Goldman Sachs in 1992. Learn more about your ...
8 Joulu 202017min
Markets Update: What Investors Are Watching Going into Year-End
Moran Forman of Goldman Sachs’ Global Markets Division gives her take on how institutional investors are viewing market pricing and volatility going into the last few weeks of the year. Learn more abo...
4 Joulu 202010min
November Wrap: Record Inflows into Global Equities
Scott Rubner of Goldman Sachs' Global Markets Division breaks down the record-setting November in equity markets and talks about investor sentiment going into year-end. Learn more about your ad choic...
1 Joulu 202017min
Asia-Pacific Economic Outlook for 2021
Andrew Tilton, chief Asia-Pacific economist for Goldman Sachs Research, talks about his team’s economic outlook for Asia-Pacific in 2021, and why they’re forecasting above-consensus growth. “We’re opt...
24 Marras 202010min
Markets Update: The Bull Run in 2021
Goldman Sachs Research remains confident about the global recovery in 2021, says Peter Oppenheimer, the firm’s chief global equity strategist. “We are optimistic for equity markets, risk assets and in...
20 Marras 202012min
Germany’s Economic Recovery
Wolfgang Fink, CEO of Germany and Austria for Goldman Sachs, talks about why Germany’s economy has weathered the pandemic better than that of many of its European neighbors and what’s ahead on the roa...
17 Marras 202018min
Markets Update: A Biden Presidency, a Possible Vaccine and the Future of the S&P
David Kostin, Goldman Sachs Research’s Chief U.S. Equity Strategist, looks back at an events-heavy week and what it means for markets in the days ahead. Learn more about your ad choices. Visit megapho...
13 Marras 202011min
Vaccine Progress and What’s Next
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for...
12 Marras 20209min
